Legal & General Group PLC Concert Pharmaceuticals, Inc. Transaction History

Legal & General Group PLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$3.77 - $5.24 $12,780 - $17,763	-3,390 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$4.86 - $13.07 $4,218 - $11,344	868 Added 34.42%	3,390 $17,000
Q3 2020 Nov 13, 2020	SELL	$8.67 - $10.82 $9,615 - $11,999	-1,109 Reduced 30.54%	2,522 $25,000
Q2 2020 Aug 14, 2020	BUY	$7.8 - $11.52 $2,589 - $3,824	332 Added 10.06%	3,631 $36,000
Q1 2020 May 14, 2020	SELL	$5.98 - $13.09 $1,411 - $3,089	-236 Reduced 6.68%	3,299 $29,000
Q1 2019 May 15, 2019	BUY	$12.07 - $17.54 $4,321 - $6,279	358 Added 11.27%	3,535 $43,000
Q2 2018 Aug 10, 2018	BUY	$16.83 - $21.66 $84 - $108	5 Added 0.16%	3,177 $53,000
Q1 2018 May 17, 2018	SELL	$19.24 - $28.03 $26,551 - $38,681	-1,380 Reduced 30.32%	3,172 $73,000
Q4 2017 Feb 13, 2018	BUY	$13.96 - $29.05 $63,545 - $132,235	4,552	4,552 $118,000

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.